期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物缓释系统应用于玻璃体视网膜疾病的研究进展

下载PDF
导出
摘要 玻璃体视网膜疾病如增殖性玻璃体视网膜增殖性疾病、视网膜色素变性、青光眼等是常见的致盲性慢性眼病,其治疗方法的研究一直是科学界的难点。利用药物缓释系统行眼内局部药物治疗是实现高效、持久、低毒药物治疗的有效手段。
作者 荣先芳 莫晓芬
机构地区 复旦大学附属眼耳鼻喉科医院眼科
出处 《中国眼耳鼻喉科杂志》 2009年第6期396-398,共3页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 教育部新世纪优秀人才支持计划(NCET-05-0370)
关键词 玻璃体视网膜疾病 药物缓释系统 局部药物治疗 视网膜色素变性 增殖性疾病 治疗方法 致盲性 青光眼
分类号 R774.1 [医药卫生—眼科] R318.08 [医药卫生—生物医学工程]
  • 相关文献

参考文献20

  • 1EBRAHIM S, PEYMAN G A, Lee P J. Applications of liposomes in ophthahnology [ J ]. Surv Ophthalmol, 2005, 50 ( 2 ) : 167-182.
  • 2VELPANDIAN T, NARAYANAN K, NAG T C, et al. Retinal toxicity of intravitreally injected plain and liposome formulation of fluconazole in rabbit eye [ J ]. Indian J Ophthalmol, 2006, 54 (4) : 237 -240.
  • 3SHINOHARA K, TANAKA M, SAKUMA T, et al. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy [ J]. Ophthalmic Surg Lasers Imaging, 2003, 34(4) :299-305.
  • 4贡亦清,陈逖,石春和,殷孝健,周敏,陈永东.氟尿嘧啶脂质体玻璃体注射防治增生性玻璃体视网膜病变的实验研究[J].眼外伤职业眼病杂志,2008,30(2):90-92. 被引量：2
  • 5BOURGES J L, GAUTIER S E, DELIE F, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles [ J ]. Invest Ophthalmol Vis Sci, 2003,44 ( 8 ) : 3562-3569.
  • 6NKANSAH M, TZENG S Y, HOLDT A M, et al. Poly(lacticcoglycolic acid ) nanospheres and microspheres for short- and long- term delivery of bioactive ciliary neurotrophic factor [ J ]. Biotechnol Bioeng, 2008,100(5 ) : 1010-1019.
  • 7ZHONG L, BRADLEY J, SCHUBERT W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice [ J ]. Invest Ophthalmol Vis Sci, 2007,48 ( 3 ) : 1212-1218.
  • 8LIBBY R T, ANDERSON M G, PANG I H, et al. Inherited glaucoma in DBA/2J mice: Pertinent disease features for studying the neurodegeneration [ J ]. Vis Neurosci, 2005, 22 (5) : 637-648.
  • 9WARD M S, KHOOBEHI A, LAVIK E B, et al. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres[ J]. J Phann Sci, 2007, 96 (3) :558-568.
  • 10SAKAI T, KUNO N, TAKAMATSU F, et al. Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats[ J]. Invest Ophthalmol Vis Sci, 2007, 48(7) :3381-3387.

二级参考文献17

  • 1梁厚成,惠延年.道诺霉素脂质体防治实验性增殖性玻璃体视网膜病变[J].中华眼底病杂志,1993,9(2):77-80. 被引量：8
  • 2贡亦清,石春和,陈逖.氟尿嘧啶脂质体玻璃体内注射对兔视网膜毒性[J].眼外伤职业眼病杂志,2005,27(12):884-886. 被引量：1
  • 3Rachal WF,Burton TC.Changing concepts of failures after retinal detachment surgery.Arch Ophthalmol,1979,97:480-483.
  • 4Weller M,Wiedemann P,Heimann K.Proliferative vitreoretinopathy-is it anything more than wound healing at the wrong place? Int Ophthalmol,1990,14:105-117.
  • 5Kon CH,Occleston NL,Aylward GW,et al.Expression of vitreous cytokines in proliferative vitreoretinopathy:a prospective study.Invest Ophthalmol Vis Sci,1999,40:705-712.
  • 6Stern WH,Guerin CJ,Erickson PA,et al.Ocular toxicity of fluorouracil after vitrectomy.Am J Ophthalmol,1983,96:43-51.
  • 7Blumenkranz M,Hernandez E,Ophir A,et al.5-fluorouracil:new applications in complicated retinal detachment for an established antimetabolite.Ophthalmology,1984,91:122-130.
  • 8Stern WH,Lewis GP,Erickson PA,et al.Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.Am J Ophthalmol,1983,96:33-42.
  • 9Hegazy HM,Peyman GA,Liang C,et al.Use of perfluorocarbon liquids,silicone oil,and 5-fluorouracil in the management of experimental PVR.Int Ophthalmol,1999,22:239-246.
  • 10Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease [ J ]. Arch Ophthalmol, 1984, 102 (4) :598-604.

共引文献9

中国眼耳鼻喉科杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部